← Issue №19/ week of Nov 8, 2026/Colorectal

Risk of Distant Metastasis and Oncologic Outcomes of Clinical Near-Complete Responders After Neoadjuvant Therapy in Rectal Cancer: A Meta-Analysis.

From GI Signals issue №19: what this paper found, what it changes, and where it sits against the current standard of care, reviewed by Simon Mathews, MD.

Colorectal meta analysis · n=1,763 · Nov 3, 2026 · Dis Colon Rectum · IF 3.5

Risk of Distant Metastasis and Oncologic Outcomes of Clinical Near-Complete Responders After Neoadjuvant Therapy in Rectal Cancer: A Meta-Analysis.

New evidencerectal cancermeta-analysis
Clinical takeawayWeigh the higher metastasis and regrowth risk when offering watch-and-wait to near-complete responders; this analysis compares response groups and does not test whether surgery improves outcomes.
What it foundNear-complete response after neoadjuvant therapy for rectal cancer is associated with higher risk of distant metastasis (16.8% vs 7.3%; RR 2.31) and local regrowth (32.8% vs 19.7%; RR 1.75) compared to complete clinical response.
ContextTen studies, 1,763 patients; definitions of near-complete response and reassessment timing varied.
No standard claimed for this paper

Every paper is compared to the standard governing its question. This one is not: either no standard in the corpus matches it, or the comparison did not hold up on review and was withdrawn rather than published unverified. Both are logged.

Marcolin P … Messaris E · Diseases of the Colon and Rectum · IF 3.5 · PubMed ↗Permalink
← Read the whole of issue №19 Every paper GI Signals surfaces gets a page like this one. All issues